Hip Arthroscopy Postoperative Opioid Demands

This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.

NCT Number	NCT04094701
Lead Sponsor	Rush University Medical Center
Conditions	Opioid Use, Pain, Femoral Acetabular Impingement, Labral Tear, Glenoid
Enrollment	170 participants
Start Date	2020-10-21
Primary Completion	2027-11 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-13